Watch Demo

Portugal Anti Rheumatic Industry Outlook 2022 - 2026

See how Portugal Anti Rheumatic performed compared to key markets such as South Korea, Germany and Spain.

Key Market Indicators

Portuguese antirheumatic medicine sales are expected to drop to $75 million by 2026. The market has been in decline since 2005, with an average rate of 3.7% year on year. In 2021, Portugal was the seventh-largest market for the product, with $98.45 million in sales. Belgium was in first place, followed by Germany, Spain and Canada, which made up the top four.

Marketing Banner

Portugal Anti Rheumatic Market Data and Forecasts

How much will Portugal Anti Rheumatic Market grow to 2026?

Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Use in Portugal
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Portugal
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Portugal
More in Anti Rheumatic Industry for 2028

Improve your Knowledge with the latest Indicators and Trends